Showing 21 - 40 results of 57,272 for search '(( a ((((teer decrease) OR (mean decrease))) OR (linear decrease)) ) OR ( i large increases ))', query time: 0.51s Refine Results
  1. 21
  2. 22

    Overexpression of <i>RECQL4</i> results in increased RAD51 foci and decreased tail moment. by Thong T. Luong (13833935)

    Published 2022
    “…The experiment was performed four times and the mean and standard deviation was graphed (Unprocessed tail moments in <b><a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1010122#pgen.1010122.s016" target="_blank">S10 Data</a></b>).…”
  3. 23

    Brief Report: Increased technology use associated with lower A1C in a large pediatric clinical population by G. Todd Alonso (9568724)

    Published 2023
    “…</p> <p><strong>Results</strong><br> CGM use increased from 32.9% to 75.3%; HCL increased from 0.3% to 27.9%. Overall A1C decreased from 8.9% to 8.6% (p<0.0001). </p> <p><strong>Conclusions</strong></p> <p>Adoption of CGM and HCL was associated with decreased A1C, suggesting promotion of these technologies may yield glycemic benefits.…”
  4. 24
  5. 25
  6. 26

    Y-27632 collaborated with BA to attenuate the increase in the integrity and decrease in the permeability of epithelial barrier injury induced by LPS in Caco2 monolayers. by Luqiong Liu (11537092)

    Published 2024
    “…<p>(<b>A)</b> Y-27632 collaborated with BA to attenuate the effect of LPS on TEER in Caco2 cells on days 1–22. …”
  7. 27
  8. 28

    Decreased brain-derived neurotrophic factor plasma levels in psoriasis patients by A.R. Brunoni (5694239)

    Published 2019
    “…Our finding, that BDNF is decreased in psoriasis, supports the concept of a brain-skin connection in psoriasis. …”
  9. 29
  10. 30
  11. 31
  12. 32
  13. 33
  14. 34
  15. 35

    K2 increases the intracellular killing of <i>K</i>. <i>pneumoniae</i> by <i>phg1a KO</i> cells. by Estelle Ifrid (10076719)

    Published 2022
    “…<i>pneumoniae</i> by <i>phg1a</i> KO cells (mean ± SEM; *: p<0.05; Kruskal-Wallis test, Dunn’s test. …”
  16. 36
  17. 37

    Baseline patient characteristics. by Oscar F. C. van den Bosch (22184246)

    Published 2025
    “…Their median baseline variabilities of respiratory rate and tidal volume were 0.19 (IQR: 0.16–0.25) and 0.23 (0.19–0.34), respectively. While mean respiratory rate was not affected, midazolam resulted in a significant decrease in both VRR (ß = −0.071, 95% CI: −0.120 to −0.021) and VTV (ß = −0.117, 95% CI: −0.170 to −0.062). …”
  18. 38
  19. 39
  20. 40